Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: swisstrader who wrote (1140)	3/8/2000 6:28:00 PM
From: Roads End	Read Replies (1) \| Respond to of 1605

Swiss, He is very interested in the upcoming conference where the University of Pittsburgh study will be released and discussed, next week I think. One of the bigger keys that will propel VASO to higher profitability, in his mind, was the approval out of Medicare. They are very conservative when it comes to giving approval but when it comes it is like God himself giving the seal of approval. He feels the strategy Medicare sees in this therapy is one of prevention and therefore cost savings to the Medicare program. Along the same reasoning he gave me another issue to look at OSTX. I haven't looked at it closely yet but his estimation is it is a huge winner over the next couple years. Here is a web site he also gave me for research and ideas, it too looks like a winner. investinlife.com